VISKEN

This brand name is authorized in Brazil, Canada, France, Germany, Mexico.

Active ingredients

The drug VISKEN contains one active pharmaceutical ingredient (API):

1	Pindolol UNII BJ4HF6IU1D - PINDOLOL
	Pindolol is a potent beta-adrenoceptor antagonist (beta-blocker) with uses similar to those of propranolol. It is classified as non cardioselective. It blocks both B1- and B2-adrenoceptors for more than 24 hours after administration. It has negligible membrane-stabilising activity. Pindolol exhibits low cardiodepressant activity at therapeutic dose.
	Read more about Pindolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C07AA03	Pindolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AA Beta blocking agents, non-selective
Discover more medicines within C07AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	526516301115417
CA	Health Products and Food Branch	00417270, 00443174
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	03547940, 03547957, 03549407, 03968067, 04966751, 07394315
FR	Base de données publique des médicaments	61252667, 66057308
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	75418